Full-Time

Assistant Nurse Director

Medical ICU, Medical Surgical ICU

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$118.4k - $172.2k/yr

+ Differentials + Premiums + Bonuses

Boston, MA, USA

In Person

Bachelor's, Master's, PhD

Category
Medical, Clinical & Veterinary (1)
Required Skills
Nursing
Patient Care
ACLS
Data Analysis

Get referred to Mass General Brigham

See people who can refer or advise you

Requirements
  • Current registration in nursing in the Commonwealth of Massachusetts is required.
  • A Bachelor's of Nursing degree is required.
  • Current certification is required or must be attained within two years of the hire date and maintained throughout employment.
  • Two to three years of nursing experience are required.
  • Critical care clinical nursing experience is required.
  • The role requires clinical expertise in the assigned area.
  • The role requires the ability to utilize management concepts in the direct supervision of nursing and non-nursing personnel.
  • The role requires effective decision-making and the ability to provide leadership to nursing and non-nursing personnel.
  • The role requires effective interpersonal communication skills.
  • The role is responsible for directly and indirectly supervising registered nurses, technical personnel, and support personnel.
  • The role reports to the nurse director of the designated area.
  • The role involves working in patient-care environments with exposure to communicable diseases and hazardous materials.
Responsibilities
  • Promote, facilitate, and support excellent nursing practice and the Department of Nursing's vision, as well as unit-based mission, values, and goals.
  • Facilitate collaboration, effective communication, and respect for diverse perspectives through role-modeling and coaching clinical staff and members of the interprofessional team.
  • Participate in daily huddles and rounds with clinical staff for clinical consultation, coaching, and problem-solving.
  • Manage day-to-day staffing for staff nurses, charge nurses, patient care associates, unit coordinators, and other ancillary staff according to unit-based guidelines.
  • Allocate resources to respond to changes in patient census and acuity.
  • Provide guidance to clinical staff on patient assignments and facilitate clinical staff development.
  • Participate in scheduling and approve clinical staff requests under the direction of the nurse director.
  • Participate in investigations and administration of corrective action, including performance improvement plans based on objective data, direct observation, clinical practice, quality metrics, and documented performance concerns.
  • Provide the nurse director with recommendations for corrective action, performance improvement plans, and clinical staff evaluations.
  • Partner with the nurse director to establish measurable quality and operational goals, monitor progress, evaluate outcomes, and sustain improvements.
  • Participate in the investigation, root-cause analysis, follow-up, and resolution of patient safety events, quality concerns, and operational issues.
  • Collaborate with the nurse director and interdisciplinary team to develop and implement action plans that improve clinical outcomes, patient safety, staff performance, and patient experience.
  • Lead or participate in quality and performance improvement initiatives using evidence-based practices, data analysis, Lean principles, PDSA methodology, audits and reviews, and other recognized quality-improvement frameworks.
  • Promote continuous improvement, accountability, and psychological safety by encouraging staff to identify safety concerns, report improvement opportunities, participate in problem-solving, and contribute to sustainable solutions.
Desired Qualifications
  • An MSN, DNP, PhD, or Master's degree in a related field is preferred.
  • CCRN or ACLS certification is preferred.
  • Leadership experience is preferred.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.9B

Headquarters

Cambridge, Massachusetts

Founded

2008

Get referred to Mass General Brigham

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 2025 operating income reached $59 million, with $240 million efficiency savings announced.
  • The January 12, 2026 Tampa General JV opened a Palm Beach Gardens radiation center.
  • August 2026 Network Bio collaboration expands MGB biobank access for AI drug discovery.

What critics are saying

  • April 29, 2026 nurses picketed over 0% raises, closures, and $35.9 million executive pay.
  • July 8, 2026 strike and lockout hit 4,700 nurses; August 11 talks remained stalled.
  • Persistent labor conflict drives temp-nurse dependence, service instability, and brand damage through 2026.

What makes Mass General Brigham unique

  • MGB Ventures gets first access to Mass General and Brigham discoveries across 2008-present.
  • The research network spans premier hospitals, enabling proprietary clinical-deal sourcing.
  • The January 12, 2026 Tampa General JV extends academic-medical brands into Florida outpatient care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

Claris Bio
Jul 29th, 2026
07-28-2026 Press Releases from Claris Bio

Latest Press Releases from Claris Bio.

Fierce Healthcare
Jun 15th, 2026
InStride Health lands $30M series C to expand pediatric mental health services

InStride Health, a provider of virtual specialty mental healthcare for children and young adults, has raised $30 million in Series C funding led by Echo Health Ventures and FMZ Ventures. Existing investors including .406 Ventures, General Catalyst and Mass General Brigham Ventures also participated. Founded in 2021, InStride offers insurance-based treatment for anxiety and obsessive-compulsive disorder in patients aged seven to 24. The company pairs each patient with a care team comprising a psychiatrist, therapist and exposure coach, providing support through text and a mobile application. InStride has treated 5,000 patients across 17 states, primarily on the East Coast and Texas. The company published data showing 97% of patients demonstrated clinical improvement, with a 53% average reduction in anxiety scores. The funding will support expansion into new markets and strengthen payer partnerships.

Associated Press
May 13th, 2026
Violet Therapeutics raises $4.75M to advance synaptic preservation therapy for neurodegenerative diseases

Violet Therapeutics, a biotechnology company developing therapies for neurodegenerative diseases, has raised $4.75 million in a seed extension round led by Lifespan Vision Ventures. Dementia Discovery Fund, UTEC, Ono Venture Investment and Mass General Brigham Ventures also participated. The Cambridge-based company will use the funding to advance its lead small molecule programme targeting EphB3 through IND-enabling activities. The therapy aims to halt and potentially reverse cognitive decline through glial-mediated synaptic preservation, addressing synaptic loss, the strongest predictor of cognitive decline in Alzheimer's and other neurodegenerative diseases. Violet's proprietary CONNECT platform maps cell-cell interaction networks to identify novel therapeutic targets. Founded by Mass General Brigham Ventures with researchers from Brigham and Women's Hospital, the company is developing first-in-class CNS therapies.

PR Newswire
Apr 23rd, 2026
Brigham nurses to picket as MGB executives earn $35.9M amid service closures and 0% wage offer

Registered nurses at Brigham and Women's Hospital will hold an informational picket on 29 April, protesting Mass General Brigham's corporate decisions affecting patient care and workforce conditions. The Massachusetts Nurses Association represents the nurses, who will demonstrate from 14:00 to 16:00 outside the hospital at 75 Francis Street, Boston. Nurses cite several service closures under MGB, including the Weiner Centre, Burn Unit and Integrated Care Management Programme. They criticise the health system's bargaining proposals, particularly a 0% wage offer for nurses below top step, whilst MGB reported a $59.2 million operating gain in 2025 and paid its top 14 executives $35.9 million in fiscal year 2024. The informational picket will not disrupt patient care, with nurses participating outside working hours.

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.